beta-galactosidase
beta-galactosidase
Overview
Beta-galactosidase (β-galactosidase, often abbreviated β-Gal) is a glycosidase enzyme that catalyzes the hydrolysis of β-galactosides into monosaccharides. In biology and medicine, it is widely recognized both as a functional enzyme involved in carbohydrate metabolism and as a practical biomarker in experimental systems. Its activity is commonly used to report cellular senescence, stress responses, and changes in tissue state, making it relevant in aging research, cancer biology, and diagnostic assay development.
In plant biology, β-galactosidase participates in cell wall remodeling, including pectin-associated processes that influence fruit softening and texture changes during ripening or mechanical stress. In biomedical research, elevated β-galactosidase activity is frequently associated with senescent cells and is used as a readout in studies of therapy-induced senescence, environmental injury, and age-related tissue dysfunction. The enzyme is also a target for analytical probes and inhibitor screening platforms, reflecting its value as both a biological marker and an assay target.
Focus of Latest Publications
Recent publications have examined beta-galactosidase in several distinct contexts, including biomarker development, fluorescence-based detection, enzyme immobilization, and plant texture biology. In GM1 gangliosidosis, beta-galactosidase deficiency was linked to accumulation of the glycan biomarker H3N2b, which was measured in plasma, urine, and cerebrospinal fluid using LC-MS/MS. H3N2b was markedly elevated in affected patients, showed strong diagnostic performance across matrices, correlated with disease severity, and decreased after AAV9-mediated GLB1 gene therapy in parallel with changes in beta-galactosidase activity, supporting its use as a pharmacodynamic biomarker.
Several studies focused on beta-galactosidase as an analytical target. A ratiometric fluorescence assay based on FRET and inner-filter effects enabled sensitive detection of beta-galactosidase in complex samples, including human serum, urine, and ripe fruits, and was also used to screen for inhibitors in herbal extracts. Another work introduced a wash-free near-infrared beta-galactosidase-activated probe for ovarian cancer organoids, where enzymatic activation allowed noninvasive imaging of chemotherapy response and produced readouts that correlated with standard viability assays. These studies highlight beta-galactosidase as a practical enzymatic readout for both diagnostic sensing and functional assessment of treatment efficacy.
Beta-galactosidase was also used in biocatalysis research. A spatially ordered coimmobilization strategy based on SpyTag/SpyCatcher chemistry and site-directed mutagenesis was developed to assemble dual-enzyme systems containing beta-galactosidase and LFAI on SiO2 supports. The immobilized systems showed improved thermal stability, solvent tolerance, storage stability, and reusability compared with free enzymes, and the directed coimmobilization approach substantially increased cascade efficiency. In a separate correspondence, beta-galactosidase was discussed in the context of a pH-responsive core-shell tablet designed for lactase intolerance, indicating continued interest in formulation strategies for oral enzyme delivery.
In plant biology, beta-galactosidase was implicated in vibration-induced texture deterioration in kiwifruit. Transcript analysis showed that vibration stress increased expression of pectin-degrading and pectin-modifying genes, including beta-galactosidase, alongside polygalacturonase and pectin methylesterase, while 1-methylcyclopropene treatment downregulated these genes and helped preserve pectin integrity. These findings connect beta-galactosidase with pectin solubilization and cell wall remodeling during postharvest mechanical stress.